{"title":"Evaluation of Potential Drug-Drug Interactions in Hypercholesterolemia Patients at Teaching Hospital Surabaya","authors":"A. Faizah, N. D. Nurrahman","doi":"10.2991/ahsr.k.210115.064","DOIUrl":null,"url":null,"abstract":"Drug-drug interactions increase the effectiveness of therapy but can also have undesirable effects on toxicity. A pharmacist has the responsibility to prevent the undesirable effect of drug-drug interactions. The purpose of this study was to evaluate the potential drug-drug interactions in hypercholesterolemia patients at Teaching Hospital Surabaya. This study was conducted with a prospective method for a month. We obtained 54 patients and identified 45 patients that have potential drug-drug interactions. The total potential drug-drug interactions were 101. The severity of potential drug-drug interactions is serious (24,7%) and moderate (75,3%). Based on the mechanism action of drug interactions are pharmacodynamics (59,4%), pharmacokinetics (32,7%), and unknown (7,9%). The role of the pharmacist in providing safe, effective and rational drug therapy can be done by either identifying drug interactions, prevent and minimize the negative effect of drug interactions.","PeriodicalId":222657,"journal":{"name":"Proceedings of the 4th International Conference on Sustainable Innovation 2020–Health Science and Nursing (ICoSIHSN 2020)","volume":"72 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the 4th International Conference on Sustainable Innovation 2020–Health Science and Nursing (ICoSIHSN 2020)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2991/ahsr.k.210115.064","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Drug-drug interactions increase the effectiveness of therapy but can also have undesirable effects on toxicity. A pharmacist has the responsibility to prevent the undesirable effect of drug-drug interactions. The purpose of this study was to evaluate the potential drug-drug interactions in hypercholesterolemia patients at Teaching Hospital Surabaya. This study was conducted with a prospective method for a month. We obtained 54 patients and identified 45 patients that have potential drug-drug interactions. The total potential drug-drug interactions were 101. The severity of potential drug-drug interactions is serious (24,7%) and moderate (75,3%). Based on the mechanism action of drug interactions are pharmacodynamics (59,4%), pharmacokinetics (32,7%), and unknown (7,9%). The role of the pharmacist in providing safe, effective and rational drug therapy can be done by either identifying drug interactions, prevent and minimize the negative effect of drug interactions.